ENHANCING ONCOLOGY STUDY WITH INTEGRATED KRAS ASSAY PRODUCTS AND SERVICES AND RAS ASSAYS

while in the fast evolving discipline of oncology research, accurate and productive mutation screening is critical for producing qualified therapies. The KRAS providers System performs a pivotal function in this landscape by presenting extensive remedies for KRAS mutation profiling and analysis. KRAS mutations, found in close to 95% of RAS-related